Sanofi's Viehbacher Interview on Genzyme, Oct. 5, 2010

Loading player, please wait...
  • Info

  • Comments

Oct. 5 (Bloomberg) -- Chris Viehbacher, chief executive officer of Sanofi-Aventis SA discusses the company's $18.5 billion hostile takeover offer for Genzyme Corp. Sanofi, France’s largest drugmaker, made its offer hostile without increasing an Aug. 29 bid that the U.S. biotechnology company spurned as too low after refusing to negotiate. Viehbacher talked yesterday with Bloomberg's Carol Massar. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change